Citations 1
Phase I interim safety and efficacy of venetoclax (ABT-199/GDC-0199) monotherapy for relapsed/refractory (R/R) multiple myeloma (MM).
Kumar, Shaji , Vij, Ravi , Alzate, Stefanie, Morris, Lura, Dunbar, Martin, Zhu, Ming , Enschede, Sari H., Humerickhouse, Rod, Kaufman, Jonathan L. , Mıkhael, Joseph , Facon, Thierry T.F. , Moreau, Philippe , Amiot, Martine , Ross, Jeremy A. , Agarwal, Suresh K, Leverson, Joel D. , Touzeau, Cyrille
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 8576-8576
